ETFChannel.com
Invesco Dynamic Biotechnology & Genome ETF

Fund Name:
Invesco Dynamic Biotechnology & Genome ETF
Issuer:
Invesco
Total Net Assets:
$237,805,200
Inception:
06/23/2005
Related Index:
DZOTR
ETF Category: 
Health
Expense Ratio: 
0.57% 
Net Asset Value: 
$61.29  
Recent NAV Premium: 
0.00% 
NAV Symbol: 
PBE.NV  
Number of Holdings: 
31  
Annualized Yield: 
0.00%  
Annualized Distribution: 
0.000  
Stock Weight Amount
Biogen 6.72% $15,988,224
Regeneron Pharmaceuticals 6.28% $14,931,522
Vertex Pharmaceuticals 5.40% $12,849,319
Gilead Sciences 5.26% $12,502,077
Biomarin Pharmaceutical 4.94% $11,758,996
List of all 31 stocks held by PBE »
Quotes delayed 20 minutes

Email EnvelopeFree PBE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Buy (3.14 out of 4)
11st percentile
(ranked lower than approx. 89% of all etfs covered)
Based on data provided by Zacks Investment Research via Quandl.com
Shares Short 5,893
Chg. from Last Month -683
Shares Outstanding 3,880,000
% of Shares Short 0.15%
Days to Cover 0.6
Based on third party short interest data.

PBE | Invesco Dynamic Biotechnology & Genome ETF | ETF Channel | www.ETFChannel.com

Copyright © 2010 - 2022, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.